683 Randomised, double-blind, active-controlled phase III study to assess the long-term safety and efficacy of mirabegron in overactive bladder (OAB)
Year: 2012
Type: conference-abstract
Source: European Urology Supplements
Authors: C.R. Chapple, S. Kaplan, H.D. Mitcheson, J. Klecka, J. Cummings, T. Drogendijk, C. Dorrepaal, N.E. Martin
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2006432065
